Archford Capital Strategies, LLC
Source: SEC Form 13F · as of Mar 2026Archford Capital Strategies, LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $35.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$35.7M
| Company | Shares | Value |
|---|---|---|
| NVSNovartis AG | 50,600 | $7.7M |
| JNJJOHNSON & JOHNSON | 26,976 | $6.6M |
| MRKMerck & Co., Inc. | 34,345 | $4.1M |
| CORCencora Inc. | 10,698 | $3.4M |
| LLYELI LILLY & Co | 2,491 | $2.3M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 30,759 | $1.7M |
| IDXXIDEXX LABORATORIES INC /DE | 2,961 | $1.7M |
| MCKMcKesson Corporation | 1,505 | $1.3M |
| ABBVAbbVie Inc. | 5,737 | $1.2M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,038 | $802K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,863 | $775K |
| MEDPMedpace Holdings Inc. | 1,573 | $755K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 2,036 | $674K |
| CAHCardinal Health Inc. | 2,891 | $611K |
| PFEPFIZER INC | 18,565 | $521K |
| PMPhilip Morris International Inc | 2,360 | $390K |
| AMGNAMGEN INC | 1,054 | $371K |
| IQVIQVIA Holdings Inc. | 2,031 | $346K |
| HALOHALOZYME THERAPEUTICS, INC. | 3,736 | $241K |
| ABTABBOTT LABORATORIES | 2,317 | $238K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.